Is severe liver disease a common outcome for people with chronic hepatitis C? - sprookjes - yvandenbroek - TriplyDB

Is severe liver disease a common outcome for people with chronic hepatitis C?

Is severe liver disease a common outcome for people with chronic hepatitis C?

http://www.wikidata.org/entity/Q34619377

about

Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews Synergic effect of chronic hepatitis C infection and beta thalassemia major with marked hepatic iron overload on liver fibrosis: a retrospective cross-sectional study Accelerated failure time models for censored survival data under referral bias.Should patients with abnormal liver function tests in primary care be tested for chronic viral hepatitis: cost minimisation analysis based on a comprehensively tested cohort.Regulation of hepatocyte fate by interferon-γ.Predicting progression to cirrhosis in chronic hepatitis C virus infection."Seek, test, treat and retain" for hepatitis C in the United States criminal justice system.HIV, Hepatitis B and C among people who inject drugs: high prevalence of HIV and Hepatitis C RNA positive infections observed in Delhi, India.Prevention of hepatitis C virus infection.Recent developments in target identification against hepatitis C virus.Effectiveness and cost-effectiveness of initial combination therapy with interferon/peginterferon plus ribavirin in patients with chronic hepatitis C in Germany: a health technology assessment commissioned by the German Federal Ministry of Health an Estimation of utilities for chronic hepatitis C from SF-36 scores.Is laparoscopy an advantage in the diagnosis of cirrhosis in chronic hepatitis C virus infection?Estimating the number of people with hepatitis C virus who have ever injected drugs and have yet to be diagnosed: an evidence synthesis approach for Scotland.No evidence of hepatitis C virus infection in Serbian patients with oral leukoplakia.Antiviral combination therapy with interferon/peginterferon plus ribavirin for patients with chronic hepatitis C in Germany: a health technology assessment commissioned by the German Agency for Health Technology Assessment.microRNA changes in liver tissue associated with fibrosis progression in patients with hepatitis C.Future therapies for chronic hepatitis C.Relative effects of heavy alcohol use and hepatitis C in decompensated chronic liver disease in a hospital inpatient population.Population-attributable estimates for risk factors associated with hepatitis B and C: policy implications for Pakistan and other South Asian countries.Response rates to combination therapy for chronic HCV infection in a clinical setting and derivation of probability tables for individual patient management.Cost-effectiveness of pegylated IFN-alpha2b and -2a and ribavirin for chronic hepatitis C treatment.Jugular venipuncture and other innovative approaches to phlebotomy among people who inject drugs.Strategies for the treatment of Hepatitis C in an era of interferon-free therapies: what public health outcomes do we value most?Interferon alpha induced intrahepatic pSTAT1 inversely correlate with serum HCV RNA levels in chronic HCV infection.Incidence, risk factors and causes of death in an HIV care programme with a large proportion of injecting drug users.Psychiatric morbidity and its effect on the quality of life of patients with chronic hepatitis B and hepatitis C.The increasing mortality burden of liver disease among opioid-dependent people: cohort study.Hospitalization rates associated with hepatitis B and HIV co-infection, age and sex in a population-based cohort of people diagnosed with hepatitis C.Global Mortality Burden of Cirrhosis and Liver Cancer Attributable to Injection Drug Use, 1990-2016: An Age-Period-Cohort and Spatial Autocorrelation Analysis.Gonadal dysfunction in adult male patients with thalassemia major: an update for clinicians caring for thalassemia.Cost-effectiveness of peginterferon alfa-2b in combination with ribavirin as initial treatment for chronic hepatitis C in Sweden.Epidemiology of hepatitis C virus in Pennsylvania state prisons, 2004-2012: limitations of 1945-1965 birth cohort screening in correctional settings.Quality of life of women living with hepatitis C.Evolving Trends in the Hepatitis C Virus Molecular Epidemiology Studies: From the Viral Sequences to the Human Genome

P2860

Q24630669-9949AADF-E3F1-4CF8-958F-44E75A31FBA5 Q24801527-2C805337-8396-4BC7-AF4C-11F66C14F0FB Q30577871-145E6962-083D-4028-9C1B-C4AFD68B0195 Q33836312-DA7B37D3-C43D-4E63-B9BE-7E08536A355E Q34748063-6D6B8969-40A2-4D7D-9577-7529943A884E Q35161346-FF3644FD-BC83-4495-A33D-9AEF488E1806 Q35174428-007A8D00-0007-4AD0-BF2C-90ACF680ADB3 Q35724789-F9BAA336-A359-4CEE-B217-E9037BA0EC79 Q35760264-E8736BE8-90A6-4E07-AFF2-ED4572300258 Q35842500-CA9309D7-EC6A-42F0-AF89-13942FF7F040 Q36057039-8A7D5161-B750-4D97-BB88-A946C1A37076 Q36060018-9A151CF8-4009-463C-A8AA-D5E58FB8D458 Q36178685-4AB90EAA-0AFA-417E-93F3-240325E8DF71 Q36554358-8D1A8895-6AD3-4A56-99D3-44E6DAA7D6DB Q36619692-30DCEDCB-A6CE-40E0-9583-A3D17DF760F2 Q37244056-5082B9D6-30C2-49A1-97D9-748E288CD290 Q37309033-419E2B7A-D5D6-446A-9CD4-CD6CCDAA6F87 Q38082566-58E824F5-501C-459A-9B58-3B1F58AD3954 Q38260704-16E2E2B9-1CCC-4F95-978B-ED33DDED6A03 Q38552236-132DE908-596B-47D1-A0ED-8028E4BFAD33 Q40143308-04877F85-9D3D-4A37-848B-28415970CD49 Q40479083-4D64CFC9-A7BA-4FB4-A3ED-7A37CE4B702D Q41034076-6604FA45-0D09-4C4A-9D3F-789D2E39AFD9 Q41672541-FAA95C9E-6CAE-423B-B63A-6F4F9B2EE420 Q42256633-8653C500-2B43-4ED0-A052-3F30BB61209B Q42982907-FF36FA5E-2915-49EC-BBF3-C45084A2A48E Q43430812-45E7A3C2-7D73-4439-9ECA-9725445D23A1 Q44351562-3A54AA34-C214-4C1B-9D66-1F5FE607AA9F Q45085512-1EE2364B-C05F-49F2-BE69-0377A9E5C4B1 Q47800804-A09318AA-3F49-4370-A0D5-9D81B0852632 Q50087928-2E0FAECD-9A55-4BD9-BC36-E51878E06F88 Q50575997-F22633F9-8198-4B19-9C4C-616ECD3702E3 Q51846147-80C4EBDC-FA4A-4317-94CD-0FE1EDC2639F Q53362029-23779DDB-24D5-4C6B-8E59-11B4FCDD238A Q58701375-A77FEA13-989A-462B-B5F1-A4C7E7C5B619

P2860

Is severe liver disease a common outcome for people with chronic hepatitis C?

http://www.wikidata.org/entity/Q34619377

description

2002 nî lūn-bûn

@nan

2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Is severe liver disease a common outcome for people with chronic hepatitis C?

@ast

Is severe liver disease a common outcome for people with chronic hepatitis C?

@en

Is severe liver disease a common outcome for people with chronic hepatitis C?

@nl

type

label

Is severe liver disease a common outcome for people with chronic hepatitis C?

@ast

Is severe liver disease a common outcome for people with chronic hepatitis C?

@en

Is severe liver disease a common outcome for people with chronic hepatitis C?

@nl

prefLabel

Is severe liver disease a common outcome for people with chronic hepatitis C?

@ast

Is severe liver disease a common outcome for people with chronic hepatitis C?

@en

Is severe liver disease a common outcome for people with chronic hepatitis C?

@nl

P1433

Q34619377-49CA43FC-887E-4E94-B1D9-1EC96AEA06EE

P1476

Q34619377-195BA18D-B68F-4F80-922B-2DCE9FC3D20F

P2093

Q34619377-0DF12B72-90A9-46C9-9671-12CECE4DFFA4

Q34619377-96DABD2D-BF68-470E-BD33-14E0CF6E9D29

Q34619377-E69A7FF8-2B5A-49CC-8B96-72392C044A10

Q34619377-F45E18BA-AC90-4E07-9F6A-8B9D672F0F57

P2860

Q34619377-02A1531A-0A77-4375-BB31-0866E3467445

Q34619377-06AC50FF-2967-4A31-AE35-4450DEFF2A75

Q34619377-08963862-38A5-402F-95A4-4A6E4E2CB6B9

Q34619377-0F11D12C-DF4A-4E53-955B-7A522AF244AA

Q34619377-1628ADFC-7B43-4C43-AC6C-7EF6CDFE599D

Q34619377-22286289-F147-4000-9AEF-47C47D9CF52A

Q34619377-27CA0FD5-FBF8-46BF-B6E4-F6E2EA33C127

Q34619377-29EB708D-CBB6-471B-BBB8-733C3C168A64

Q34619377-3CB6854D-2E47-4503-8E3C-5EAE5D37C706

Q34619377-40986487-D562-4025-8AE9-61DB39F3D1A5

P304

Q34619377-B903D2F5-4CA0-4C35-8CD8-AA8BD4196E8B

P31

Q34619377-79B36504-A621-41AF-AC2E-09CA88039339

P356

Q34619377-607A3464-6856-466B-87A9-AE0127F2107D

P433

Q34619377-59A66D46-16D7-41D8-BBE9-D6429736D5BB

P478

Q34619377-7EC68772-0B0D-4677-AC1F-58632A27D546

P577

Q34619377-8C36FAF0-6B4D-4945-BD3C-BC2221F1F79A

P698

Q34619377-7E28869E-9CF2-4135-B3B0-B7BC8C5AFD6A

P356

J.1440-1746.2002.02730.X

P1433

Journal of Gastroenterology and Hepatology

P1476

Is severe liver disease a common outcome for people with chronic hepatitis C?

@en

P2093

Anthony J Freeman

http://www.w3.org/2001/XMLSchema#string

Gregory J Dore

http://www.w3.org/2001/XMLSchema#string

John M Kaldor

http://www.w3.org/2001/XMLSchema#string

Matthew Law

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical course and risk factors of hepatitis C virus related liver disease in the general population: report from the Dionysos study

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

Epidemiology of hepatitis C: geographic differences and temporal trends

Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response

Assessment of long-term outcomes of hepatitis C virus infection in a cohort of patients with acute hepatitis in 1971-1975: results of a pilot study.

Persistence of viremia and the importance of long-term follow-up after acute hepatitis C infection.

Estimating progression to cirrhosis in chronic hepatitis C virus infection.

Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients.

Long-term mortality and morbidity of transfusion-associated non-A, non-B, and type C hepatitis: A National Heart, Lung, and Blood Institute collaborative study.

P304

423-430

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1046/J.1440-1746.2002.02730.X

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P577

2002-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11982723

http://www.w3.org/2001/XMLSchema#string